REPAY HOLDINGS CORPORATION RPAY 深 沪
等待开盘 09-10 09:30:00 美东时间
5.985
+0.065
+1.10%
华盛通- 最 高5.985
- 今 开5.90
- 成交量 28.22万股
- 最 低 5.86
- 昨 收 5.92
- 总市值 4.88亿
- 52周最高 9.75
- 市盈率 静 --
- 换手率 0.35%
- 52周最低 3.59
- 委 比 -36.21%
- 总股本 8154.87万
- 历史最高 28.42
- 量 比 0.48
- 振 幅 2.11%
- 历史最低 3.59
- 每 手 1
- 风险率 1.31%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多REPAY And Alfa Partner To Provide Secure And Convenient Payment Acceptance Capabilities For Alfa's Users
Partnership Enables Omni-channel and Digital Payment Acceptance for Automotive and Equipment Financing Across North America
09-09 20:36
Canaccord Genuity Maintains Buy on Repay Holdings, Maintains $12 Price Target
Canaccord Genuity analyst Joseph Vafi maintains Repay Holdings (NASDAQ:RPAY) with a Buy and maintains $12 price target.
08-25 21:10
Morgan Stanley Maintains Equal-Weight on Repay Holdings, Raises Price Target to $5
Morgan Stanley analyst James Faucette maintains Repay Holdings (NASDAQ:RPAY) with a Equal-Weight and raises the price target from $4.5 to $5.
08-12 20:32
Repay Holdings Sees Growth Amidst Q2 Challenges
Repay Holdings ( ($RPAY) ) has released its Q2 earnings. Here is a breakdown of...
08-12 11:58
Earnings Scheduled For August 11, 2025
Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to rep...
08-11 16:32
Repay Holdings Conducts Annual Stockholders Meeting
Repay Holdings ( ($RPAY) ) just unveiled an update. On June 12, 2025, Repay Hol...
06-14 05:35
美股大行评级 | 潜在涨幅300.0%！HC Wainwright & Co.：Armata Pharmaceuticals获机构升目标价至9美元，维持"买入"评级
潜在涨幅300.0%！HC Wainwright & Co.：Armata Pharmaceuticals获机构升目标价至9美元，维持"买入"评级
05-21 16:44
美股大行评级 | 摩根大通：维持网易"超配"评级，目标价升至135美元；瑞银上调达美航空评级至"买入"
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1131517965561573377.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Armata Pharmaceuticals(ARMP)"买入"评级，目标价从7美元升至9美元</p> <p>• 瑞银：维持爱芬奇(ANF)"买入"评级，目标价从115美
05-20 09:28
美股大行评级 | 潜在涨幅158.9%！蒙特利尔银行上调Disc Medicine目标价至120美元，维持"跑赢大市"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1129333511617925121.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 蒙特利尔银行：维持Disc Medicine(IRON)"跑赢大市"评级，目标价从112美元升至120美元</p> <p>• 巴克莱：维持Karyopharm Therapeutics(KPTI)"超配"评级，目标价从5美
05-14 08:48
